FPA Medical Management - FPAMQ Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : FPA Medical Management - FPAMQ

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ALAN DENZINE who wrote (956)	7/17/1998 1:02:00 PM
From: Douglas V. Fant	of 1110

Alan, There is no evidence that previous mgt "manipulated" cash flow figures. There were all in the 10K Report if studied carefully. But you are right about the tangible assets. That is why FPAM is worth a whole lot more to creditors alive than dead with a $1b revenue stream, and why the creditors will likely try to help FPAM get back on its feet. FPAM previously stated that it believed that it could return to cash flow positive by 4th quarter. That's only a couple of months away. So I bet that the creditors will "bide their time" and see if FPAM can succeed in trimming costs, raising revenues through new deals, and refocusing upon what it considers to be its core business... Sincerely, Doug F.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next